{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "Intravenous immunoglobulins", "Myocarditis", "SARS-CoV-2", "Vaccine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35380300", "DateRevised": {"Year": "2023", "Month": "09", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "04", "Day": "05"}], "Language": ["eng"], "ELocationID": ["23", "10.1186/s43044-022-00260-2"], "Journal": {"ISSN": "2090-911X", "JournalIssue": {"Volume": "74", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Apr", "Day": "05"}}, "Title": "The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology", "ISOAbbreviation": "Egypt Heart J"}, "ArticleTitle": "COVID-19 and myocarditis: a review of literature.", "Pagination": {"StartPage": "23", "MedlinePgn": "23"}, "Abstract": {"AbstractText": ["Myocarditis has been discovered to be a significant complication of coronavirus disease 2019 (COVID-19), a condition caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. COVID-19 myocarditis seems to have distinct inflammatory characteristics, which make it unique to other viral etiologies. The incidence of COVID-19 myocarditis is still not clear as a wide range of figures have been quoted in the literature; however, it seems that the risk of developing myocarditis increases with more severe infection. Furthermore, the administration of the mRNA COVID-19 vaccine has been associated with the development of myocarditis, particularly after the second dose. COVID-19 myocarditis has a wide variety of presentations, ranging from dyspnea and chest pain to acute heart failure and possibly death. It is important to catch any cases of myocarditis, particularly those presenting with fulminant myocarditis which can be characterized by signs of heart failure and arrythmias. Initial work up for suspected myocarditis should include serial troponins and electrocardiograms. If myocardial damage is detected in these tests, further screening should be carried out. Cardiac magnetic resonance imagining and endomyocardial biopsy are the most useful tests for myocarditis. Treatment for COVID-19 myocarditis is still controversial; however, the use of intravenous immunoglobulins and corticosteroids in combination may be effective, particularly in cases of fulminant myocarditis. Overall, the incidence of COVID-19 myocarditis requires further research, while the use of intravenous immunoglobulins and corticosteroids in conjunction requires large randomized controlled trials to determine their efficacy."], "CopyrightInformation": "\u00a9 2022. The Author(s)."}, "AuthorList": [{"Identifier": ["0000-0003-3933-0333"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, The University of Manchester, Stopford Building, 99 Oxford Road, Manchester, M13 9PG, UK. mohammed.ali-24@student.manchester.ac.uk."}], "LastName": "Ali", "ForeName": "Mohammed", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Burnley General Hospital, Burnley, UK."}], "LastName": "Shiwani", "ForeName": "Haaris A", "Initials": "HA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, University College Dublin, Dublin, Ireland."}], "LastName": "Elfaki", "ForeName": "Mohammed Y", "Initials": "MY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Birmingham Midland Eye Centre, Birmingham, UK."}], "LastName": "Hamid", "ForeName": "Moaz", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "St Vincent's University Hospital, Dublin, Ireland."}], "LastName": "Pharithi", "ForeName": "Rebabonye", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "St Vincent's University Hospital, Dublin, Ireland."}], "LastName": "Kamgang", "ForeName": "Rene", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, University of N'Djamena, N'djamena, Chad."}], "LastName": "Egom", "ForeName": "Christian BinounA", "Initials": "CB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Endocrinology and Radioisotopes, Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaound\u00e9, Cameroon."}], "LastName": "Oyono", "ForeName": "Jean Louis Essame", "Initials": "JLE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Endocrinology and Radioisotopes, Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaound\u00e9, Cameroon."}, {"Identifier": [], "Affiliation": "Institut du Savoir Montfort (ISM), H\u00f4pital Montfort, 713 Montreal Rd, Ottawa, ON, K1K 0T2, Canada."}], "LastName": "Egom", "ForeName": "Emmanuel Eroume-A", "Initials": "EE"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Egypt Heart J", "NlmUniqueID": "9106952", "ISSNLinking": "1110-2608"}, "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533\u2013534. doi: 10.1016/S1473-3099(20)30120-1.", "ArticleIdList": ["10.1016/S1473-3099(20)30120-1", "PMC7159018", "32087114"]}, {"Citation": "Cascella M, Rajnik M, Aleem A, Dulebohn SC, di Napoli R (2021)Features, Evaluation, and Treatment of Coronavirus (COVID-19)", "ArticleIdList": ["32150360"]}, {"Citation": "WHO Coronavirus (COVID-19) Dashboard. Covid19.who.int. Accessed September 13, 2021. https://covid19.who.int/"}, {"Citation": "Parasher A. COVID-19: current understanding of its pathophysiology, clinical presentation and treatment. Postgrad Med J. 2021;97(1147):312. doi: 10.1136/postgradmedj-2020-138577.", "ArticleIdList": ["10.1136/postgradmedj-2020-138577", "PMC10017004", "32978337"]}, {"Citation": "Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450\u2013454. doi: 10.1038/nature02145.", "ArticleIdList": ["10.1038/nature02145", "PMC7095016", "14647384"]}, {"Citation": "Belouzard S, Millet JK, Licitra BN, Whittaker GR. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 2012;4(6):1011\u20131033. doi: 10.3390/v4061011.", "ArticleIdList": ["10.3390/v4061011", "PMC3397359", "22816037"]}, {"Citation": "Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782\u2013793. doi: 10.1001/jama.2020.12839.", "ArticleIdList": ["10.1001/jama.2020.12839", "32648899"]}, {"Citation": "Mele D, Flamigni F, Rapezzi C, Ferrari R. Myocarditis in COVID-19 patients: current problems. Intern Emerg Med. 2021;16(5):1123\u20131129. doi: 10.1007/s11739-021-02635-w.", "ArticleIdList": ["10.1007/s11739-021-02635-w", "PMC7823176", "33484452"]}, {"Citation": "Marcinkiewicz K, Petryka-Mazurkiewicz J, Nowicki M, et al. Acute heart failure in the course of fulminant myocarditis requiring mechanical circulatory support in a healthy young patient after coronavirus disease 2019. Kardiologia Polska (Polish Heart J) 2021;79(5):583\u2013584. doi: 10.33963/KP.15888.", "ArticleIdList": ["10.33963/KP.15888", "34125938"]}, {"Citation": "Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(7):819\u2013824. doi: 10.1001/jamacardio.2020.1096.", "ArticleIdList": ["10.1001/jamacardio.2020.1096", "PMC7364333", "32219357"]}, {"Citation": "Pascariello G, Cimino G, Calvi E, et al. Cardiogenic shock due to COVID-19-related myocarditis in a 19-year-old autistic patient. J Med Cases. 2020;11(7):207\u2013210. doi: 10.14740/jmc3517.", "ArticleIdList": ["10.14740/jmc3517", "PMC8040434", "33984092"]}, {"Citation": "Cooper LT., Jr Myocarditis. N Engl J Med. 2009;360(15):1526\u20131538. doi: 10.1056/NEJMra0800028.", "ArticleIdList": ["10.1056/NEJMra0800028", "PMC5814110", "19357408"]}, {"Citation": "Baboonian C, Treasure T. Meta-analysis of the association of enteroviruses with human heart disease. Heart (British Cardiac Society) 1997;78(6):539\u2013543. doi: 10.1136/hrt.78.6.539.", "ArticleIdList": ["10.1136/hrt.78.6.539", "PMC1892342", "9470867"]}, {"Citation": "Caforio ALP, Calabrese F, Angelini A, et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J. 2007;28(11):1326\u20131333. doi: 10.1093/eurheartj/ehm076.", "ArticleIdList": ["10.1093/eurheartj/ehm076", "17493945"]}, {"Citation": "Agrawal AS, Garron T, Tao X, et al. Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease. J Virol. 2015;89(7):3659\u20133670. doi: 10.1128/JVI.03427-14.", "ArticleIdList": ["10.1128/JVI.03427-14", "PMC4403411", "25589660"]}, {"Citation": "Esfandiarei M, McManus BM. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol. 2008;3(1):127\u2013155. doi: 10.1146/annurev.pathmechdis.3.121806.151534.", "ArticleIdList": ["10.1146/annurev.pathmechdis.3.121806.151534", "18039131"]}, {"Citation": "Seko Y, Takahashi N, Yagita H, Okumura K, Yazaki Y. Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus B3. J Pathol. 1997;183(1):105\u2013108. doi: 10.1002/(SICI)1096-9896(199709)183:1<105::AID-PATH1094>3.0.CO;2-E.", "ArticleIdList": ["10.1002/(SICI)1096-9896(199709)183:1<105::AID-PATH1094>3.0.CO;2-E", "9370955"]}, {"Citation": "Cihakova D, Sharma R, Fairweather D, Afanasyeva M, Rose N. Animal models for autoimmune myocarditis and autoimmune thyroiditis. Methods Mol Med. 2004;102:175\u2013193. doi: 10.1385/1-59259-805-6:175.", "ArticleIdList": ["10.1385/1-59259-805-6:175", "15286386"]}, {"Citation": "Zhang P, Cox CJ, Alvarez KM, Cunningham MW. Cutting edge: cardiac myosin activates innate immune responses through TLRs. J Immunol (Baltimore, Md) 2009;183(1):27\u201331. doi: 10.4049/jimmunol.0800861.", "ArticleIdList": ["10.4049/jimmunol.0800861", "PMC2720835", "19535635"]}, {"Citation": "Blyszczuk P, Kania G, Dieterle T, et al. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy. Circ Res. 2009;105(9):912\u2013920. doi: 10.1161/CIRCRESAHA.109.199802.", "ArticleIdList": ["10.1161/CIRCRESAHA.109.199802", "19762681"]}, {"Citation": "Baldeviano GC, Barin JG, Talor Mv, et al. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circul Res. 2010;106(10):1646\u20131655. doi: 10.1161/CIRCRESAHA.109.213157.", "ArticleIdList": ["10.1161/CIRCRESAHA.109.213157", "20378858"]}, {"Citation": "Oleszak F, Maryniak A, Botti E, et al. Myocarditis associated With COVID-19. Am J Med Case Rep. 2020;8(12):498\u2013502. doi: 10.12691/ajmcr-8-12-19.", "ArticleIdList": ["10.12691/ajmcr-8-12-19", "0"]}, {"Citation": "Qian Z, Travanty EA, Oko L, et al. Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Am J Respir Cell Mol Biol. 2013;48(6):742\u2013748. doi: 10.1165/rcmb.2012-0339OC.", "ArticleIdList": ["10.1165/rcmb.2012-0339OC", "PMC3727876", "23418343"]}, {"Citation": "Goulter AB, Goddard MJ, Allen JC, Clark KL. ACE2 gene expression is up-regulated in the human failing heart. BMC Med. 2004;2:19. doi: 10.1186/1741-7015-2-19.", "ArticleIdList": ["10.1186/1741-7015-2-19", "PMC425604", "15151696"]}, {"Citation": "Sharma YP, Agstam S, Yadav A, Gupta A, Gupta A. Cardiovascular manifestations of COVID-19: an evidence-based narrative review. Indian J Med Res. 2021;153(1 & 2):7\u201316. doi: 10.4103/ijmr.IJMR_2450_20.", "ArticleIdList": ["10.4103/ijmr.IJMR_2450_20", "PMC8184068", "33818464"]}, {"Citation": "Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020;22(5):911\u2013915. doi: 10.1002/ejhf.1828.", "ArticleIdList": ["10.1002/ejhf.1828", "PMC7262276", "32275347"]}, {"Citation": "Oudit GY, Kassiri Z, Jiang C, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39(7):618\u2013625. doi: 10.1111/j.1365-2362.2009.02153.x.", "ArticleIdList": ["10.1111/j.1365-2362.2009.02153.x", "PMC7163766", "19453650"]}, {"Citation": "Siripanthong B, Nazarian S, Muser D, et al. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17(9):1463\u20131471. doi: 10.1016/j.hrthm.2020.05.001.", "ArticleIdList": ["10.1016/j.hrthm.2020.05.001", "PMC7199677", "32387246"]}, {"Citation": "Kawakami R, Sakamoto A, Kawai K, et al. Pathological evidence for SARS-CoV-2 as a cause of myocarditis: JACC review topic of the week. J Am Coll Cardiol. 2021;77(3):314\u2013325. doi: 10.1016/j.jacc.2020.11.031.", "ArticleIdList": ["10.1016/j.jacc.2020.11.031", "PMC7816957", "33478655"]}, {"Citation": "Fox SE, Li G, Akmatbekov A, et al. Unexpected features of cardiac pathology in COVID-19 infection. Circulation. 2020;142(11):1123\u20131125. doi: 10.1161/CIRCULATIONAHA.120.049465.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.120.049465", "32689809"]}, {"Citation": "Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet (London, England) 2020;395(10234):1417\u20131418. doi: 10.1016/S0140-6736(20)30937-5.", "ArticleIdList": ["10.1016/S0140-6736(20)30937-5", "PMC7172722", "32325026"]}, {"Citation": "Fox SE, Falgout L, vandar Heide RS. COVID-19 myocarditis: quantitative analysis of the inflammatory infiltrate and a proposed mechanism. Cardiovasc Pathol. 2021;54:107361. doi: 10.1016/j.carpath.2021.107361.", "ArticleIdList": ["10.1016/j.carpath.2021.107361", "PMC8223028", "34174415"]}, {"Citation": "Lee DW, Gardner R, Porter DL, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124(2):188\u2013195. doi: 10.1182/blood-2014-05-552729.", "ArticleIdList": ["10.1182/blood-2014-05-552729", "PMC4093680", "24876563"]}, {"Citation": "Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25\u201332. doi: 10.1016/j.cytogfr.2020.05.003.", "ArticleIdList": ["10.1016/j.cytogfr.2020.05.003", "PMC7211650", "32446778"]}, {"Citation": "Talasaz AH, Sadeghipour P, Kakavand H, et al. Recent randomized trials of antithrombotic therapy for patients with COVID-19: JACC state-of-the-art review. J Am Coll Cardiol. 2021;77(15):1903\u20131921. doi: 10.1016/j.jacc.2021.02.035.", "ArticleIdList": ["10.1016/j.jacc.2021.02.035", "PMC7963001", "33741176"]}, {"Citation": "Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666\u20131687. doi: 10.1093/cvr/cvaa106.", "ArticleIdList": ["10.1093/cvr/cvaa106", "PMC7197627", "32352535"]}, {"Citation": "Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(7):811\u2013818. doi: 10.1001/jamacardio.2020.1017.", "ArticleIdList": ["10.1001/jamacardio.2020.1017", "PMC7101506", "32219356"]}, {"Citation": "Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531\u2013538. doi: 10.1007/s00392-020-01626-9.", "ArticleIdList": ["10.1007/s00392-020-01626-9", "PMC7087935", "32161990"]}, {"Citation": "Halushka MK, vandar Heide RS. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol. 2021;50:107300. doi: 10.1016/j.carpath.2020.107300.", "ArticleIdList": ["10.1016/j.carpath.2020.107300", "PMC7583586", "33132119"]}, {"Citation": "Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(11):1265\u20131273. doi: 10.1001/jamacardio.2020.3557.", "ArticleIdList": ["10.1001/jamacardio.2020.3557", "PMC7385689", "32730619"]}, {"Citation": "Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802\u2013810. doi: 10.1001/jamacardio.2020.0950.", "ArticleIdList": ["10.1001/jamacardio.2020.0950", "PMC7097841", "32211816"]}, {"Citation": "Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846\u2013848. doi: 10.1007/s00134-020-05991-x.", "ArticleIdList": ["10.1007/s00134-020-05991-x", "PMC7080116", "32125452"]}, {"Citation": "Lagan\u00e0 N, Cei M, Evangelista I, et al. Suspected myocarditis in patients with COVID-19: a multicenter case series. Medicine. 2021;100(8):e24552\u2013e24552. doi: 10.1097/MD.0000000000024552.", "ArticleIdList": ["10.1097/MD.0000000000024552", "PMC7909099", "33663062"]}, {"Citation": "Omidi F, Hajikhani B, Kazemi SN, et al. COVID-19 and cardiomyopathy: a systematic review. Front Cardiovasc Med. 2021;8:695206. doi: 10.3389/fcvm.2021.695206.", "ArticleIdList": ["10.3389/fcvm.2021.695206", "PMC8248804", "34222385"]}, {"Citation": "Guo J, Wei X, Li Q, et al. Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury. J Cell Physiol. 2020;235(12):9884\u20139894. doi: 10.1002/jcp.29802.", "ArticleIdList": ["10.1002/jcp.29802", "PMC7301022", "32510598"]}, {"Citation": "Ma M, Xu Y, Su Y, et al. Single-cell transcriptome analysis decipher new potential regulation mechanism of ACE2 and NPs signaling among heart failure patients infected with SARS-CoV-2. Front Cardiovasc Med. 2021 doi: 10.3389/fcvm.2021.628885.", "ArticleIdList": ["10.3389/fcvm.2021.628885", "PMC7952310", "33718452"]}, {"Citation": "Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116(6):1097\u20131100. doi: 10.1093/cvr/cvaa078.", "ArticleIdList": ["10.1093/cvr/cvaa078", "PMC7184507", "32227090"]}, {"Citation": "Pan D, Sze S, Minhas JS, et al. The impact of ethnicity on clinical outcomes in COVID-19: a systematic review. EClinicalMedicine. 2020;23:100404. doi: 10.1016/j.eclinm.2020.100404.", "ArticleIdList": ["10.1016/j.eclinm.2020.100404", "PMC7267805", "32632416"]}, {"Citation": "Myers VD, Gerhard GS, McNamara DM, et al. Association of variants in BAG3 with cardiomyopathy outcomes in African American Individuals. JAMA Cardiol. 2018;3(10):929\u2013938. doi: 10.1001/jamacardio.2018.2541.", "ArticleIdList": ["10.1001/jamacardio.2018.2541", "PMC6233818", "30140897"]}, {"Citation": "Leigh JA, Alvarez M, Rodriguez CJ. Ethnic minorities and coronary heart disease: an update and future directions. Curr Atheroscler Rep. 2016;18(2):9. doi: 10.1007/s11883-016-0559-4.", "ArticleIdList": ["10.1007/s11883-016-0559-4", "PMC4828242", "26792015"]}, {"Citation": "Abuelgasim E, Saw LJ, Shirke M, Zeinah M, Harky A. COVID-19: Unique public health issues facing Black, Asian and minority ethnic communities. Curr Probl Cardiol. 2020;45(8):100621. doi: 10.1016/j.cpcardiol.2020.100621.", "ArticleIdList": ["10.1016/j.cpcardiol.2020.100621", "PMC7207142", "32448759"]}, {"Citation": "Vinciguerra M, Greco E. Sars-CoV-2 and black population: ACE2 as shield or blade? Infection Genetics Evol J Mol Epidemiol Evolut Genetics Infect Diseases. 2020;84:104361. doi: 10.1016/j.meegid.2020.104361.", "ArticleIdList": ["10.1016/j.meegid.2020.104361", "PMC7219352", "32405281"]}, {"Citation": "Maron BJ, Udelson JE, Bonow RO, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015 doi: 10.1161/CIR.0000000000000239.", "ArticleIdList": ["10.1161/CIR.0000000000000239", "26621644"]}, {"Citation": "Daniels CJ, Rajpal S, Greenshields JT, et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection. JAMA Cardiol. 2021 doi: 10.1001/jamacardio.2021.2065.", "ArticleIdList": ["10.1001/jamacardio.2021.2065", "PMC8160916", "34042947"]}, {"Citation": "Rajpal S, Tong MS, Borchers J, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. 2021;6(1):116\u2013118. doi: 10.1001/jamacardio.2020.4916.", "ArticleIdList": ["10.1001/jamacardio.2020.4916", "PMC7489396", "32915194"]}, {"Citation": "Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021;144(6):471\u2013484. doi: 10.1161/CIRCULATIONAHA.121.056135.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.121.056135", "PMC8340726", "34281357"]}, {"Citation": "Diaz GA, Parsons GT, Gering SK, Meier AR, Hutchinson Iv, Robicsek A. Myocarditis and pericarditis after vaccination for COVID19. JAMA. 2021 doi: 10.1001/jama.2021.13443.", "ArticleIdList": ["10.1001/jama.2021.13443", "PMC8340007", "34347001"]}, {"Citation": "Abu Mouch S, Roguin A, Hellou E, et al. Myocarditis following COVID-19 mRNA vaccination. Vaccine. 2021;39(29):3790\u20133793. doi: 10.1016/j.vaccine.2021.05.087.", "ArticleIdList": ["10.1016/j.vaccine.2021.05.087", "PMC8162819", "34092429"]}, {"Citation": "Kim HW, Jenista ER, Wendell DC, et al. Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA Cardiol. 2021 doi: 10.1001/jamacardio.2021.2828.", "ArticleIdList": ["10.1001/jamacardio.2021.2828", "PMC8243258", "34185046"]}, {"Citation": "Shaw KE, Cavalcante JL, Han BK, G\u00f6ssl M. Possible association between COVID-19 vaccine and myocarditis: clinical and CMR findings. JACC Cardiovasc Imaging. 2021;14(9):1856\u20131861. doi: 10.1016/j.jcmg.2021.06.002.", "ArticleIdList": ["10.1016/j.jcmg.2021.06.002", "PMC8245050", "34246586"]}, {"Citation": "Montgomery J, Ryan M, Engler R, et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol. 2021 doi: 10.1001/jamacardio.2021.2833.", "ArticleIdList": ["10.1001/jamacardio.2021.2833", "PMC8243257", "34185045"]}, {"Citation": "Dionne A, Sperotto F, Chamberlain S, et al. Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA Cardiol. 2021 doi: 10.1001/jamacardio.2021.3471.", "ArticleIdList": ["10.1001/jamacardio.2021.3471", "PMC8356143", "34374740"]}, {"Citation": "Bhopal SS, Bagaria J, Olabi B, Bhopal R. Children and young people remain at low risk of COVID-19 mortality. Lancet Child Adolescent Health. 2021;5(5):e12\u2013e13. doi: 10.1016/S2352-4642(21)00066-3.", "ArticleIdList": ["10.1016/S2352-4642(21)00066-3", "PMC7946566", "33713603"]}, {"Citation": "D\u2019Angelo T, Cattafi A, Carerj ML, et al. Myocarditis after SARS-CoV-2 vaccination: a vaccine-induced reaction? Can J Cardiol. 2021 doi: 10.1016/j.cjca.2021.05.010.", "ArticleIdList": ["10.1016/j.cjca.2021.05.010", "PMC8187737", "34118375"]}, {"Citation": "Al-Akchar M, Kiel J (2021) Acute Myocarditis", "ArticleIdList": ["28722877"]}, {"Citation": "Kim IC, Kim JY, Kim HA, Han S. COVID-19-related myocarditis in a 21-year-old female patient. Eur Heart J. 2020;41(19):1859. doi: 10.1093/eurheartj/ehaa288.", "ArticleIdList": ["10.1093/eurheartj/ehaa288", "PMC7184491", "32282027"]}, {"Citation": "Das BB. SARS-CoV-2 myocarditis in a high school athlete after COVID-19 and its implications for clearance for sports. Children (Basel, Switzerland) 2021;8(6):427. doi: 10.3390/children8060427.", "ArticleIdList": ["10.3390/children8060427", "PMC8223786", "34063781"]}, {"Citation": "Fried JA, Ramasubbu K, Bhatt R, et al. The variety of cardiovascular presentations of COVID-19. Circulation. 2020;141(23):1930\u20131936. doi: 10.1161/CIRCULATIONAHA.120.047164.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.120.047164", "PMC7314498", "32243205"]}, {"Citation": "Okor I, Sleem A, Zhang A, Kadakia R, Bob-Manuel T, Krim SR. Suspected COVID-19-induced myopericarditis. Ochsner J. 2021;21(2):181\u2013186. doi: 10.31486/toj.20.0090.", "ArticleIdList": ["10.31486/toj.20.0090", "PMC8238094", "34239379"]}, {"Citation": "Ho JS, Sia CH, Chan MY, Lin W, Wong RC. Coronavirus-induced myocarditis: a meta-summary of cases. Heart Lung J Crit Care. 2020;49(6):681\u2013685. doi: 10.1016/j.hrtlng.2020.08.013.", "ArticleIdList": ["10.1016/j.hrtlng.2020.08.013", "PMC7440036", "32861884"]}, {"Citation": "Gaine S, Devitt P, Coughlan JJ, Pearson I. COVID-19-associated myocarditis presenting as new-onset heart failure and atrial fibrillation. BMJ Case Rep. 2021;14(7):e244027. doi: 10.1136/bcr-2021-244027.", "ArticleIdList": ["10.1136/bcr-2021-244027", "PMC8276282", "34253533"]}, {"Citation": "Kociol RD, Cooper LT, Fang JC, et al. Recognition and initial management of fulminant myocarditis. Circulation. 2020;141(6):e69\u2013e92. doi: 10.1161/CIR.0000000000000745.", "ArticleIdList": ["10.1161/CIR.0000000000000745", "31902242"]}, {"Citation": "Wang Z, Wang Y, Lin H, Wang S, Cai X, Gao D. Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: a meta-analysis. Medicine. 2019;98(8):e14697\u2013e14697. doi: 10.1097/MD.0000000000014697.", "ArticleIdList": ["10.1097/MD.0000000000014697", "PMC6408109", "30813218"]}, {"Citation": "Schultz JC, Hilliard AA, Cooper LT, Jr, Rihal CS. Diagnosis and treatment of viral myocarditis. Mayo Clin Proc. 2009;84(11):1001\u20131009. doi: 10.1016/S0025-6196(11)60670-8.", "ArticleIdList": ["10.1016/S0025-6196(11)60670-8", "PMC2770911", "19880690"]}, {"Citation": "Smith SC, Ladenson JH, Mason JW, Jaffe AS (1997) Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 95(1)", "ArticleIdList": ["8994432"]}, {"Citation": "Sawalha K, Abozenah M, Kadado AJ, et al. Systematic review of COVID-19 related myocarditis: insights on management and outcome. Cardiovasc Revascular Med Include Mol Intervent. 2021;23:107\u2013113. doi: 10.1016/j.carrev.2020.08.028.", "ArticleIdList": ["10.1016/j.carrev.2020.08.028", "PMC7434380", "32847728"]}, {"Citation": "Tsch\u00f6pe C, Cooper LT, Torre-Amione G, van Linthout S. Management of myocarditis-related cardiomyopathy in adults. Circ Res. 2019;124(11):1568\u20131583. doi: 10.1161/CIRCRESAHA.118.313578.", "ArticleIdList": ["10.1161/CIRCRESAHA.118.313578", "31120823"]}, {"Citation": "Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72(24):3158\u20133176. doi: 10.1016/j.jacc.2018.09.072.", "ArticleIdList": ["10.1016/j.jacc.2018.09.072", "30545455"]}, {"Citation": "Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol. 2009;53(17):1475\u20131487. doi: 10.1016/j.jacc.2009.02.007.", "ArticleIdList": ["10.1016/j.jacc.2009.02.007", "PMC2743893", "19389557"]}, {"Citation": "Ho JS, Sia CH, Chan MY, Lin W, Wong RC. Coronavirus-induced myocarditis: a meta-summary of cases. Heart Lung J Critical Care. 2020;49(6):681\u2013685. doi: 10.1016/j.hrtlng.2020.08.013.", "ArticleIdList": ["10.1016/j.hrtlng.2020.08.013", "PMC7440036", "32861884"]}, {"Citation": "Ferreira MV, Jeanette SM, Godtfred H, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation. J Am College Cardiol. 2018;72(24):3158\u20133176. doi: 10.1016/j.jacc.2018.09.072.", "ArticleIdList": ["10.1016/j.jacc.2018.09.072", "30545455"]}, {"Citation": "Leone O, Veinot JP, Angelini A, et al. 2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol. 2012;21(4):245\u2013274. doi: 10.1016/j.carpath.2011.10.001.", "ArticleIdList": ["10.1016/j.carpath.2011.10.001", "22137237"]}, {"Citation": "Aretz HT. Myocarditis: the Dallas criteria. Human Pathol. 1987 doi: 10.1016/s0046-8177(87)80363-5.", "ArticleIdList": ["10.1016/s0046-8177(87)80363-5", "3297992"]}, {"Citation": "Secco GG, Tarantini G, Mazzarotto P, et al. Invasive strategy for COVID patients presenting with acute coronary syndrome: the first multicenter Italian experience. Catheter Cardiovasc Interv. 2021;97(2):195\u2013198. doi: 10.1002/ccd.28959.", "ArticleIdList": ["10.1002/ccd.28959", "PMC7272920", "32400049"]}, {"Citation": "Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science. 2008;320(5874):373\u2013376. doi: 10.1126/science.1154315.", "ArticleIdList": ["10.1126/science.1154315", "PMC2409116", "18420934"]}, {"Citation": "Maisch B, Hufnagel G, K\u00f6lsch S, et al. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins. Herz. 2004;29(6):624\u2013636. doi: 10.1007/s00059-004-2628-7.", "ArticleIdList": ["10.1007/s00059-004-2628-7", "15912438"]}, {"Citation": "Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. Eur Heart J. 2021;42(2):206. doi: 10.1093/eurheartj/ehaa190.", "ArticleIdList": ["10.1093/eurheartj/ehaa190", "PMC7184348", "32176300"]}, {"Citation": "Huang X, Sun Y, Su G, Li Y, Shuai X. Intravenous immunoglobulin therapy for acute myocarditis in children and adults. Int Heart J. 2019;60(2):359\u2013365. doi: 10.1536/ihj.18-299.", "ArticleIdList": ["10.1536/ihj.18-299", "30745539"]}, {"Citation": "Tsch\u00f6pe C, van Linthout SS, Pieske B, K\u00fchl U. Immunosuppression in lymphocytic myocarditis with parvovirus B19 presence. Eur J Heart Failure. 2018;20:609. doi: 10.1002/ejhf.951.", "ArticleIdList": ["10.1002/ejhf.951"]}, {"Citation": "Abdelnabi M, Eshak N, Saleh Y, Almaghraby A. Coronavirus disease 2019 myocarditis: insights into pathophysiology and management. Eur Cardiol Rev. 2020 doi: 10.15420/ecr.2020.16.", "ArticleIdList": ["10.15420/ecr.2020.16", "PMC7325211", "32617120"]}, {"Citation": "Chen HS, Wang W, Wu SN, Liu JP. Corticosteroids for viral myocarditis. Cochrane Database Syst Rev. 2013;2013(10):CD004471\u2013CD004471. doi: 10.1002/14651858.CD004471.pub3.", "ArticleIdList": ["10.1002/14651858.CD004471.pub3", "PMC8094275", "24136037"]}, {"Citation": "Zhao H, Zhu Q, Zhang C, et al. Tocilizumab combined with favipiravir in the treatment of COVID-19: a multicenter trial in a small sample size. Biomed Pharmacother. 2021;133:110825. doi: 10.1016/j.biopha.2020.110825.", "ArticleIdList": ["10.1016/j.biopha.2020.110825", "PMC7524677", "33378989"]}, {"Citation": "(2005) Part 7.3: management of symptomatic bradycardia and tachycardia. Circulation 112(24_supplement):IV-67\u2013IV-77. 10.1161/CIRCULATIONAHA.105.166558"}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "8"}, {"Year": "2022", "Month": "3", "Day": "24"}, {"Year": "2022", "Month": "4", "Day": "5", "Hour": "12", "Minute": "4"}, {"Year": "2022", "Month": "4", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "6", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "4", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["35380300", "PMC8980789", "10.1186/s43044-022-00260-2", "10.1186/s43044-022-00260-2"]}}], "PubmedBookArticle": []}